DE60003445D1 - Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend - Google Patents
Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltendInfo
- Publication number
- DE60003445D1 DE60003445D1 DE60003445T DE60003445T DE60003445D1 DE 60003445 D1 DE60003445 D1 DE 60003445D1 DE 60003445 T DE60003445 T DE 60003445T DE 60003445 T DE60003445 T DE 60003445T DE 60003445 D1 DE60003445 D1 DE 60003445D1
- Authority
- DE
- Germany
- Prior art keywords
- fluorochinolonantibiotic
- pharmaceutical compositions
- compositions containing
- xanthan gum
- xanthan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001285 xanthan gum Polymers 0.000 title 1
- 229940082509 xanthan gum Drugs 0.000 title 1
- 235000010493 xanthan gum Nutrition 0.000 title 1
- 239000000230 xanthan gum Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16269399P | 1999-11-01 | 1999-11-01 | |
PCT/US2000/028031 WO2001032181A2 (en) | 1999-11-01 | 2000-10-10 | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60003445D1 true DE60003445D1 (de) | 2003-07-24 |
DE60003445T2 DE60003445T2 (de) | 2003-12-24 |
Family
ID=22586735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60003445T Expired - Lifetime DE60003445T2 (de) | 1999-11-01 | 2000-10-10 | Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend |
Country Status (19)
Country | Link |
---|---|
US (1) | US6331540B1 (de) |
EP (1) | EP1225898B1 (de) |
JP (1) | JP2003513046A (de) |
KR (1) | KR20020048967A (de) |
CN (1) | CN1384745A (de) |
AR (1) | AR026227A1 (de) |
AT (1) | ATE243038T1 (de) |
AU (1) | AU8008300A (de) |
BR (1) | BR0015256A (de) |
CA (1) | CA2386822A1 (de) |
DE (1) | DE60003445T2 (de) |
DK (1) | DK1225898T3 (de) |
ES (1) | ES2199873T3 (de) |
HK (1) | HK1045940A1 (de) |
MX (1) | MXPA02004349A (de) |
PL (1) | PL354928A1 (de) |
PT (1) | PT1225898E (de) |
TR (1) | TR200201174T2 (de) |
WO (1) | WO2001032181A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009922A1 (en) * | 2001-01-27 | 2005-01-13 | Carlson Paul E. | Stable aqueous antimicrobial suspension |
AU2002331720B2 (en) * | 2001-08-24 | 2007-10-11 | Johns Hopkins University | Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
US8877168B1 (en) | 2002-07-31 | 2014-11-04 | Senju Pharmaceuticals Co., Ltd. | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
JP3631748B2 (ja) | 2002-07-31 | 2005-03-23 | 千寿製薬株式会社 | 水性液剤および光安定化された水性液剤 |
US8524735B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
PT1901749T (pt) * | 2005-05-18 | 2016-11-04 | Raptor Pharmaceuticals Inc | Fluoroquinolonas aerossolizadas e suas utilizações |
CA2666440A1 (en) | 2006-10-12 | 2008-04-17 | Kyorin Pharmaceutical Co., Ltd. | Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
CA2718641A1 (en) * | 2008-03-31 | 2009-10-08 | Kyorin Pharmaceutical Co., Ltd. | Gatifloxacin-containing aqueous liquid preparation, its production and method for suppressing formation of precipitate during storage at lower temperature and at the time of freezing and thawing of the aqueous liquid preparation |
BRPI0909366A2 (pt) * | 2008-03-31 | 2017-06-13 | Kyorin Seiyaku Kk | preparação líquida aquosa contendo gatifloxacina |
TWI544934B (zh) * | 2008-06-09 | 2016-08-11 | 愛爾康研究有限公司 | 含有氟喹諾酮抗生素藥物之經改良藥學組成物 |
PL2344129T3 (pl) | 2008-10-07 | 2018-07-31 | Horizon Orphan Llc | Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych |
JP2012505222A (ja) | 2008-10-07 | 2012-03-01 | エムペックス・ファーマシューティカルズ・インコーポレーテッド | 肺炎症を低減するためのレボフロキサシンの吸入 |
ES2739979T3 (es) | 2009-09-04 | 2020-02-05 | Horizon Orphan Llc | Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística |
EP2540307B1 (de) * | 2010-02-24 | 2016-05-25 | Morinaga Milk Industry Co., Ltd. | Antibakterielles hilfsmittel mit einem kombu-extrakt als wirkstoff, antibakterielle zusammensetzung und nahrungsmittel oder getränk damit |
US9050357B2 (en) * | 2010-03-08 | 2015-06-09 | Cp Kelco U.S., Inc. | Compositions and methods for producing consumables for patients with dysphagia |
GR1008168B (el) | 2013-03-14 | 2014-04-08 | "Φαρματεν Α.Β.Ε.Ε.", | Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου |
JP6538322B2 (ja) * | 2013-09-27 | 2019-07-03 | 三栄源エフ・エフ・アイ株式会社 | 液状とろみ剤 |
JP6602534B2 (ja) * | 2013-09-27 | 2019-11-06 | 三栄源エフ・エフ・アイ株式会社 | 液状とろみ剤 |
JP6713728B2 (ja) * | 2015-05-01 | 2020-06-24 | 三栄源エフ・エフ・アイ株式会社 | 液状増粘剤 |
MX2020000265A (es) | 2017-07-07 | 2020-07-22 | Epicentrx Inc | Composiciones para la administración parenteral de agentes terapéuticos. |
US11382910B2 (en) | 2020-08-26 | 2022-07-12 | Somerset Therapeutics, Llc. | Loteprednol and moxifloxacin compositions and methods |
US11298315B2 (en) | 2020-08-26 | 2022-04-12 | Somerset Therapeutics, Llc. | Triamcinolone and moxifloxacin compositions |
US11484538B2 (en) | 2020-08-26 | 2022-11-01 | Somerset Therapeutics, Llc | Bromfenac, prednisolone, and moxifloxacin compositions and methods |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3700451A (en) | 1970-04-06 | 1972-10-24 | Itek Corp | Gelable and gelled compositions |
US3944427A (en) | 1970-04-06 | 1976-03-16 | Itek Corporation | Gelable and gelled compositions |
US3784712A (en) | 1970-12-23 | 1974-01-08 | Gen Foods Corp | Gum gelling system xanthan-tara dessert gel |
CA1070629A (en) | 1975-11-10 | 1980-01-29 | Allen I. Laskin | Process for modifying biopolymers |
US4135979A (en) | 1976-08-24 | 1979-01-23 | Merck & Co., Inc. | Treatment of xanthan gum to improve clarity |
US4136173A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
US4136177A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
US4136178A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Locust bean gum therapeutic compositions |
GB8318403D0 (en) | 1983-07-07 | 1983-08-10 | Sutherland I W | Gel-forming polysaccharides |
FR2551087B1 (fr) | 1983-08-30 | 1986-03-21 | Rhone Poulenc Spec Chim | Procede de traitement d'une solution de polysaccharide et son utilisation |
DE3335593A1 (de) | 1983-09-30 | 1985-04-11 | Diamalt AG, 8000 München | Gelier- und verdickungsmittel auf der basis von cassia-galactomannanen |
US4717713A (en) | 1983-10-31 | 1988-01-05 | Research Corporation | Controlled release liquid pharmaceutical |
US4708861A (en) | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
US4647470A (en) | 1985-11-27 | 1987-03-03 | Merck & Co., Inc. | Low-acetyl gellan gum blends |
FR2618333B1 (fr) | 1987-07-20 | 1990-07-13 | Merck Sharp & Dohme | Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam |
US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
US4814160A (en) | 1988-03-01 | 1989-03-21 | Colgate-Palmolive Company | Non-bleeding striped dentifrice |
US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
DE3843416A1 (de) | 1988-12-23 | 1990-06-28 | Wolff Walsrode Ag | Xanthan mit verbesserter loeslichkeit und verfahren zur herstellung |
CA2021414C (en) | 1989-07-25 | 2004-09-28 | Daniel H. Doherty | Genetic control of acetylation and pyruvylation of xanthan gum |
US5461081A (en) | 1989-09-28 | 1995-10-24 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
FR2653021A1 (fr) | 1989-10-17 | 1991-04-19 | Merck Sharp & Dohme | Composition ophtalmique aqueuse liquide a transition de phase liquide-gel. |
DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
WO1993005816A1 (en) | 1991-09-17 | 1993-04-01 | Alcon Laboratories, Inc. | Compositions containing quinolone antibiotics and sulfonate of polystyrol |
US5192802A (en) | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
US5473062A (en) | 1992-10-29 | 1995-12-05 | Takeda Chemical Industries, Ltd. | Process for producing purified xanthan gum |
JP3228315B2 (ja) | 1993-04-23 | 2001-11-12 | 信越化学工業株式会社 | キサンタンガムの汚染生菌数を減少させる方法 |
ES2068762B1 (es) * | 1993-07-21 | 1995-12-01 | Lipotec Sa | Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion. |
WO1995019166A1 (en) | 1994-01-14 | 1995-07-20 | Shahinian Lee Jr | A method for sustained and extended corneal analgesia |
US5422116A (en) | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
DK0754032T3 (da) | 1994-04-08 | 2002-04-02 | Atrix Lab Inc | Flydende frigivelsessammensætninger |
US5523301A (en) | 1994-08-05 | 1996-06-04 | Merck & Co., Inc. | Optic nerve health |
DK0725628T3 (da) | 1994-08-30 | 2001-12-27 | Alcon Lab Inc | Termisk geldannende lægemiddelindgivelsesvehikler indeholdende celluloseethere |
US5972326A (en) | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
FR2742336B1 (fr) | 1995-12-19 | 1998-03-06 | Chauvin Lab Sa | Collyre destine notamment au traitement de l'oeil sec |
SE9603480L (sv) | 1996-09-23 | 1998-03-24 | Johan Carlfors | Beredningsform för svårlösliga läkemedel |
FR2754712B1 (fr) | 1996-10-17 | 1999-09-03 | Merck Sharp Dohme Chibret Lab | Compositions ophtalmiques |
US5888493A (en) | 1996-12-05 | 1999-03-30 | Sawaya; Assad S. | Ophthalmic aqueous gel formulation and related methods |
EP0998277A1 (de) | 1997-05-30 | 2000-05-10 | Merck & Co., Inc. (a New Jersey corp.) | Ophthalmische zusammensetzungen zur behandlung des glaukom |
CA2294343A1 (en) | 1997-06-26 | 1999-01-07 | Merck & Co., Inc. | Method for optimizing retinal and optic nerve health |
CA2302561C (en) * | 1997-09-12 | 2006-02-14 | The Procter & Gamble Company | Cleansing and conditioning article for skin or hair |
NZ506921A (en) | 1998-04-07 | 2002-02-01 | Alcon Lab Inc | Gelling ophthalmic compositions containing xanthan gum |
US6166012A (en) * | 1999-07-30 | 2000-12-26 | Allergan Sales, Inc. | Antibiotic compositions and method for using same |
-
2000
- 2000-10-10 CN CN00815003A patent/CN1384745A/zh active Pending
- 2000-10-10 TR TR2002/01174T patent/TR200201174T2/xx unknown
- 2000-10-10 ES ES00970752T patent/ES2199873T3/es not_active Expired - Lifetime
- 2000-10-10 MX MXPA02004349A patent/MXPA02004349A/es not_active Application Discontinuation
- 2000-10-10 EP EP00970752A patent/EP1225898B1/de not_active Expired - Lifetime
- 2000-10-10 PL PL00354928A patent/PL354928A1/xx unknown
- 2000-10-10 AT AT00970752T patent/ATE243038T1/de active
- 2000-10-10 PT PT00970752T patent/PT1225898E/pt unknown
- 2000-10-10 JP JP2001534386A patent/JP2003513046A/ja not_active Withdrawn
- 2000-10-10 DE DE60003445T patent/DE60003445T2/de not_active Expired - Lifetime
- 2000-10-10 AU AU80083/00A patent/AU8008300A/en not_active Abandoned
- 2000-10-10 WO PCT/US2000/028031 patent/WO2001032181A2/en active IP Right Grant
- 2000-10-10 CA CA002386822A patent/CA2386822A1/en not_active Abandoned
- 2000-10-10 DK DK00970752T patent/DK1225898T3/da active
- 2000-10-10 BR BR0015256-0A patent/BR0015256A/pt not_active Application Discontinuation
- 2000-10-10 US US09/686,083 patent/US6331540B1/en not_active Expired - Lifetime
- 2000-10-10 KR KR1020027004809A patent/KR20020048967A/ko not_active Application Discontinuation
- 2000-10-24 AR ARP000105597A patent/AR026227A1/es unknown
-
2002
- 2002-10-07 HK HK02107339.3A patent/HK1045940A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN1384745A (zh) | 2002-12-11 |
EP1225898A2 (de) | 2002-07-31 |
ES2199873T3 (es) | 2004-03-01 |
AR026227A1 (es) | 2003-01-29 |
JP2003513046A (ja) | 2003-04-08 |
HK1045940A1 (zh) | 2002-12-20 |
KR20020048967A (ko) | 2002-06-24 |
PL354928A1 (en) | 2004-03-22 |
EP1225898B1 (de) | 2003-06-18 |
US6331540B1 (en) | 2001-12-18 |
CA2386822A1 (en) | 2001-05-10 |
AU8008300A (en) | 2001-05-14 |
DK1225898T3 (da) | 2003-09-15 |
ATE243038T1 (de) | 2003-07-15 |
PT1225898E (pt) | 2003-10-31 |
MXPA02004349A (es) | 2003-09-22 |
WO2001032181A3 (en) | 2002-05-02 |
WO2001032181A2 (en) | 2001-05-10 |
TR200201174T2 (tr) | 2002-08-21 |
DE60003445T2 (de) | 2003-12-24 |
BR0015256A (pt) | 2002-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60003445T2 (de) | Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend | |
DE69924999D1 (de) | Lipasehemmer enthaltende pharmazeutische zusammensetzungen | |
FIU20000164U0 (fi) | Uusi farmaseuttinen formulaatio | |
ATE331529T1 (de) | Antigen enthaltende pharmazeutische zusammensetzung | |
DE69940904D1 (de) | Pharmazeutische zusammensetzung enthaltend epothilone | |
IL152718A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
ATE284223T1 (de) | Zusammensetzung enthaltend ein tramadol und ein antikonvulsives arzneimittel | |
EE04904B1 (et) | Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon | |
DE69904312D1 (de) | Pharmazeutische aerosolformulierung | |
DE69807420T2 (de) | Pharmazeutische aerosolzusammensetzung | |
AT7729U3 (de) | Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat | |
HUP0301949A3 (en) | Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds | |
ATE383868T1 (de) | Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka | |
DE60018081D1 (de) | Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung | |
DE10084344T1 (de) | Cyclosporin enthaltende pharmazeutische Zusammensetzung | |
DE59801987D1 (de) | Pharmazeutische zusammensetzung enthaltend peptichemio | |
IL169163A0 (en) | Optically active dihydropyridine derivative and pharmaceutical compositions containing the same | |
DE69830154D1 (de) | Pharmazeutische zusammensetzungen | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
DE69809928D1 (de) | Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen | |
ATE290543T1 (de) | Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung | |
ATE447964T1 (de) | Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor | |
HUP0203383A3 (en) | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof | |
DE60106619D1 (de) | Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi | |
DE60217369D1 (de) | Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |